Novo Nordisk’s Oral Wegovy Breaks Records, but Generics Threaten to Undercut the Party
Novo Nordisk’s oral Wegovy pill generated 2.26B DKK in Q1, doubling analyst estimates, but generic semaglutide launches in…
Browsing Tag